Pregabalin Capsules Recalled Due to Foreign Tablet Contamination During Packaging
Rising Pharma's pregabalin capsules are being recalled nationwide after a pantoprazole tablet was discovered during packaging. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recall with no reported illnesses or injuries. A single foreign tablet was discovered during packaging quality control. Although the presence of wrong medication in a prescription drug bottle represents a theoretical contamination risk, no adverse events have been reported.
Plain-English summary
Rising Pharma Holdings, Inc. is recalling Pregabalin Capsules (50mg, 1000-count bottle) distributed nationwide due to contamination discovered during repackaging.
During packaging setup, a pantoprazole tablet (20mg) was discovered in a bottle by American Health Packaging, a repackaging firm. The presence of a foreign tablet indicates a contamination event in the manufacturing or repackaging process.
The recall affects pregabalin 50mg capsules, including lot 23132611 with an expiration date of July 31, 2026.
Consumers should inspect their pregabalin bottles for any unusual tablets and contact their pharmacist or healthcare provider if they discover any tablets that do not appear to be pregabalin capsules. Do not take any tablets that look different. Consumers with questions may contact Rising Pharma Holdings, Inc.
The recalled product
- Product
- PREGABALIN (PREGABALIN)
- Brand
- PREGABALIN
- Manufacturer
- Rising Pharma Holding, Inc.
- Hazard
- foreign-tablet
- wrong-medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 23132611
- Exp 07/31/2026
UPCs (8)
- 0364980413107
- 0364980411103
- 0364980415101
- 0364980412100
- 0364980416108
- 0364980414104
- 0364980410106
- 0364980417105
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · PREGABALIN
- ModeratePregabalin Capsules Recalled for Out-of-Specification Manufacturing Defects
FDA (Drugs) · 2022-01-12
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27